Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Uniphar Plc LSE:UPR London Ordinary Share IE00BJ5FQX74 ORD EUR0.08
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 1.825 1.75 1.90 1.825 1.825 1.825 0.00 08:00:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food & Drug Retailers 1,665.3 26.5 11.5 15.9 498

Uniphar PLC AGM Update

19/05/2020 7:00am

UK Regulatory (RNS & others)


Uniphar (LSE:UPR)
Historical Stock Chart


From May 2020 to Jul 2020

Click Here for more Uniphar Charts.

TIDMUPR

RNS Number : 2730N

Uniphar PLC

19 May 2020

AGM Update

Dublin, London | 19 May 2020

As set out in the Notice of AGM published on 24 April 2020, the annual general meeting of Uniphar plc (the "Company") is scheduled to take place at 11am on 26 May 2020 at Uniphar's registered office, 4045 Kingswood Road, Citywest Business Park, Dublin 24, D24 V06K (the "AGM") .

Following the Irish Government's latest announcement on 15 May 2020 on Covid-19 restrictions, significant restrictions on internal gatherings of people not from the same household will remain in place on 26 May 2020. Accordingly, shareholders are requested not to attend the AGM in person and instead to submit a proxy form to ensure they can vote and be represented at the AGM without attending in person.

The Company regrets the need to take this step but is doing so to safeguard the health of its shareholders and employees and to ensure all government guidelines are followed, ensuring the AGM is as safe and efficient as possible.

Uniphar encourages all shareholders to avail of the other methods outlined below to ensure effective shareholder participation in the AGM.

Voting

All resolutions at the AGM will be put to a poll (which incorporates proxy votes received within the prescribed timelines prior to the meeting) and the Company will publish the results of the poll on its website following the AGM. Proxy voting can be carried out in advance of the AGM in one of the following ways: (1) by completing the Proxy Form enclosed with the Notice of AGM, (2) via the registrar's website at www.eproxyappointment.com or (3) via the CREST electronic proxy appointment service for those shareholders who are CREST members. In light of the restrictions, shareholders should appoint the Chairman of the meeting as their proxy.

Questions

Shareholders may submit questions relating to the business of the meeting in advance (so as to be received by no later than 5 p.m. on Friday, 22 May 2020) by email to the Company Secretary, Aisling McCarthy, at amccarthy@uniphar.ie or by post to the Company's registered office, marked for the attention of the Company Secretary.

Conference Call

For the convenience and safety of shareholders, the AGM will be conducted over a live conference call and shareholders may register to receive participant log-in details at www.directeventreg.com using the conference ID 7495818. The conference call facility is a listening facility only and shareholders will not be able to vote or ask questions via the conference call facility.

Updates

The Board encourages shareholders to check Regulatory Information Services and the Company's website www.uniphar.ie for any updates in relation to the AGM.

--- ENDS ---

For further details contact:

 
 Uniphar                                          +353 (0) 1 428 7777 
 
 Brian O'Shaughnessy 
                                                 ------------------------------ 
 Group Director of Corporate Development          investor.relations@Uniphar.ie 
                                                 ------------------------------ 
 
 Davy                                             +353 (0) 1 679 6363 
                                                 ------------------------------ 
 (Joint Broker, Nominated Adviser and Euronext 
  Growth Adviser) 
                                                 ------------------------------ 
 
 Fergal Meegan 
                                                 ------------------------------ 
 Barry Murphy 
                                                 ------------------------------ 
 Tom Tynan 
                                                 ------------------------------ 
 
 RBC Capital Markets (Joint Broker)               +44 (0) 20 7653 4000 
                                                 ------------------------------ 
 
 Darrell Uden 
                                                 ------------------------------ 
 Jonathan Hardy 
                                                 ------------------------------ 
 Jamil Miah 
                                                 ------------------------------ 
 
 Q4 PR                                            +353 (0) 1 475 1444 
                                                   or 
                                                 ------------------------------ 
 (Public Relations Adviser to Uniphar)            +353 87 235 6461 
                                                 ------------------------------ 
 
 Iarla Mongey 
                                                 ------------------------------ 
 

About Uniphar plc

Headquartered in Dublin, Ireland, Uniphar is an international diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,200, the Group is active in Ireland, the UK, the Benelux, the Nordics and the US.

The Company's vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar represents a strong combination of scale, growth and profitability.

Commercial & Clinical

In Commercial & Clinical the Group provides sales, marketing & distribution solutions to multinational pharmaceutical and medical device manufacturers on an outsourced basis. Active in Ireland, the UK, the Benelux and the Nordics, the Group is growing with clients to provide pan-European solutions. Uniphar have built a fully integrated multi-channel solution that is supported by highly experienced, clinically trained teams to deliver exceptional outcomes for all clients.

Product Access

In Product Access the Group is growing two distinct service offerings: 1) "On-Demand Access", which are pharmacy led solutions for sourcing and supplying unlicensed medicines to meet the needs of both retail and hospital pharmacists; and 2) "Exclusive Access", which are manufacturer led solutions for controlling the release of speciality medicines for specifically approved patient populations in agreed markets. The Group currently delivers product access solutions to more than 160 markets globally.

Supply Chain & Retail

Uniphar is an established market leader in Ireland with c50% supply chain market share supported by a network of 287 owned, franchised and symbol group pharmacies. The business supports the diverse customer base through the provision of strong service levels coupled with innovative commercial initiatives. Supply Chain & Retail is an Irish only business for the Group, although the assets and infrastructure are utilised for the benefit of the growth divisions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NOAUWRURROUVAUR

(END) Dow Jones Newswires

May 19, 2020 02:00 ET (06:00 GMT)

1 Year Uniphar Chart

1 Year Uniphar Chart

1 Month Uniphar Chart

1 Month Uniphar Chart
ADVFN Advertorial
Your Recent History
LSE
UPR
Uniphar
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200703 20:17:01